When was Ibex founded?

Ibex was founded in 2016 and raised its 1st funding round 3 years after it was founded.

Where is Ibex located?

Ibex is headquartered in Tel Aviv, Israel.

How many employees does Ibex have?

As of Jul 31, 2026, the latest employee count at Ibex is 98.

Is Ibex a funded company?

Ibex is a funded company, having raised a total of $114M across 4 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on Mar 26, 2019.

When was the latest funding round of Ibex?

Ibex's latest funding was a $***** Series C round on Sep 06, 2023, with participation from 6 investors.

Where does Ibex rank among its competitors?

Ibex ranks 2nd amongst 89 active competitors, of which 36 are funded. It stands 4th in terms of total funding among its competitors. The most recent competitor to raise funding was Harbinger Health, which secured $100M in Apr, 2026.

Who are the top competitors of Ibex?

Ibex's top competitors include PAIGE, Aignostics and Onc.ai. Among them, Harbinger Health secured the most recent funding round in April, 2026.

Ibex - 2026 Company Profile, Team, Funding & Competitors

Ibex is a series C company based in Tel Aviv (Israel), founded in 2016 by Chaim Linhart. It operates as a Provider of AI-powered diagnostic solutions for pathology. Ibex has raised $114M in funding from investors like 83NORTH, Kreos Capital and Octopus Ventures. The company has 89 active competitors, including 36 funded and 4 that have exited. Its top competitors include companies like PAIGE, Aignostics and Onc.ai.

Company Details

Provider of AI-powered diagnostic solutions for pathology. The company has developed an analytical and diagnosis platform called the GALEN platform which assists with treatment diagnosis and planning. Other products such as First Read and Second Read use AI technology for the diagnosis of cancer based on pathological image analysis. The platform uses computer vision-based image analysis and machine learning technologies in digital pathology.

Website: ibex-ai.com
Social
Email ID: *****@ibex-ai.com

Key Metrics

Founded Year

2016

Location

Tel Aviv, Israel

Stage

Series C

Total Funding

$114M in 4 rounds

Latest Funding Round

Series C, Sep 06, 2023, $*****

Investors

83NORTH & 7 more

Ranked

2^nd among 89 active competitors

Employee Count

98 as on Jul 31, 2026

Similar Companies

OpenEvidence & 2909 more

View Ibex's full profile

Ibex has raised a total funding of $114M over 4 rounds. Its first funding round was on Mar 26, 2019. Its latest funding round was a Series C round on Sep 06, 2023 for $*****. 6 investors participated in its latest round. Ibex has 8 institutional investors.

Here is the list of recent funding rounds of Ibex:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Sep 06, 2023	7819842	Series C	4387438	3755423	2961164	7210001
Nov 09, 2022	8292180	Series B	5376994	2401132	7825828	6865016
Mar 09, 2021	5141025	Series B	7199494	6497034	Octopus Ventures & 1 more	aMoon & 2 more

Access funding benchmarks and valuations. Sign up today!

View details of Ibex's funding rounds and investors

The founders of Ibex is Chaim Linhart.

Here are the details of Ibex's key team members:

Chaim Linhart: Co-Founder & CTO of Ibex.
Contact Info: 1 email address

View details of Ibex's Founder profiles and Board Members

Ibex's employee count trend

Ibex has 98 employees as of Jul 26. Here is Ibex's employee count trend over the years:

Uncover Ibex's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Ibex include PAIGE, Aignostics and Onc.ai. Here is the list of Top 10 competitors of Ibex, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	PAIGE 2018, New York City (United States), Acquired	Developer of AI applications and foundation models for cancer diagnostics	$241M	Goldman Sachs, Casdin Capital & 9 others	71/100
2nd	Ibex 2016, Tel Aviv (Israel), Series C	Provider of AI-powered diagnostic solutions for pathology	$114M	Kreos Capital, Dell Technologies Capital & 6 others	68/100
3rd	Aignostics 2018, Berlin (Germany), Series B	Developer of artificial intelligence software for biomedical image analysis applications	$53.9M	Wellington Partners Venture Capital, Boehringer Ingelheim Venture Fund ... & 9 others	64/100
4th	Onc.ai 2020, San Carlos (United States), Series A	AI-based cancer treatment and diagnosis platform for healthcare providers	$31M	MassMutual, Accomplice & 12 others	61/100
5th	Valar Labs 2021, Palo Alto (United States), Series A	Developer of AI diagnostics for predicting cancer treatment response likelihood	$26.1M	Andreessen Horowitz, DCVC & 18 others	60/100
6th	Enspectra Health 2014, Mountain View (United States), Series A	Developer of medical devices for tissue imagining and cancer detection	$15.5M	Foothill Ventures, Tao Capital Partners & 6 others	59/100
7th	Proscia 2014, Philadelphia (United States), Series C	Provider of an AI and cloud-based digital pathology solution for cancer diagnosis	$129M	Triangle Peak Partners, Insight Partners ... & 22 others	59/100
8th	Harbinger Health 2008, Cambridge (United States), Series B	AI-based cancer detection tool for providers	$290M	Flagship Pioneering, M&G & 4 others	57/100
9th	Mindpeak 2017, Hamburg (Germany), Series A	Provider of AI-based pathological analysis platform	$18.3M	IFB Innovationsstarter, ZEISS & 28 others	57/100
10th	CDx Diagnostics 1997, Suffern (United States), Acquired	Provider of AI-based platform to detect precancerous tissues	$16M	Bhansali Equities, Hermes GPE & 1 others	57/100